Heymann, Dominique
Institut de Cancérologie de l’Ouest,
France
2025 Rank: 49130
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1467 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49130 | 54951 |
| Total Cites | 1395 | 1467 |
| H-index | 17 | 17 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 28 | 31 |
| Number of Single+First+Last Authored Papers | 143 | 143 |
| Total Cites to Single+First+Last Authored Papers | 620 | 647 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1222 | 1256 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
4.91%
|
|
Heymann, Dominique
CNRS Centre National de la Recherche Scientifique,
France
2024 Rank: 33107
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1048 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33107 | 33829 |
| Total Cites | 1312 | 1392 |
| H-index | 18 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 17 | 17 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 39 | 42 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 647 | 686 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1116 | 1151 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
5.75%
|
|
Heymann, Dominique
Nantes Université,
France
2023 Rank: 43057
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1518 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43057 | 42912 |
| Total Cites | 1203 | 1323 |
| H-index | 16 | 16 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 33 | 38 |
| Number of Single+First+Last Authored Papers | 136 | 136 |
| Total Cites to Single+First+Last Authored Papers | 524 | 580 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1040 | 1084 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.22 |
| Self-Citation Percentage |
9.07%
|
|
Heymann, Dominique
Université de Nantes,
France
2022 Rank: 32644
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1223 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32644 | 30253 |
| Total Cites | 1353 | 1514 |
| H-index | 17 | 20 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 40 | 47 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 613 | 679 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1122 | 1179 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.28 |
| Self-Citation Percentage |
10.63%
|
|
Heymann, Dominique
Université de Nantes,
France
2021 Rank: 36325
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1302 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36325 | 40109 |
| Total Cites | 1832 | 1991 |
| H-index | 20 | 20 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 18 | 18 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 63 | 70 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 876 | 932 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1550 | 1607 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.24 |
| Self-Citation Percentage |
7.99%
|
|
Heymann, Dominique
Universite de Nantes,
France
2020 Rank: 44876
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1575 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44876 | 38542 |
| Total Cites | 1223 | 1403 |
| H-index | 15 | 18 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 17 | 18 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 42 | 52 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 564 | 646 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1066 | 1135 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.24 |
| Self-Citation Percentage |
12.83%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.